CALQUENCE: payments to doctors
Payments that named CALQUENCE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $14.4M
- Providers
- 10,206
- Transactions
- 46,291
- Average per transaction
- $310
The per-transaction average — $310 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10,206 providers the average total is $1,408, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AstraZeneca | $12,184,263 | 84.8% |
| Acerta Pharma LLC | $1,508,992 | 10.5% |
| Astrazeneca UK Limited | $676,793 | 4.7% |